Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Hankerchiefon Jul 30, 2019 12:14pm
74 Views
Post# 29975184

RE:Time is on my side, yes it is

RE:Time is on my side, yes it isHydro,
What do you think it would take to get moving on intravenous use of tld 1433?  It seems when that is studied and implemented and if results are reflective of animal studies then it would really make things interesting. That could save a lot of lives and generate a lot of cash.  

hydrocarbss wrote: Reality:  By the time this company is known, understood and investable by the main stream investment community the share count will be in the neighborhood of 250,000,000.

At that share price, each $1Billion (US) of Market Cap would equal a share price of $4.00

With the advancements that have been made in the lasers, the ability to tweat the TLD1433 since 2016, this story is still in it's infancy.  

TLD1433 was only first used in a human in 2017.  Then in only 6 humans, and only 3 at full dosage.
Two of those 3 had their NMIBC completely eradicated and that condition lasted for 360 days.  That was the last time measure of the trial.

Who knows what advancements can be made in other non-invasive cancers over the next couple of years.

This company, in two to three years could easily have a market cap in the $10's of Billions.

With a share count of 250 million and a Market Cap of $10 Billion, each share would be valued at $40.

Owning just 25,000 shares at these prices could make one a millioinaire in just a few years.

We're talking about turning a $10,000 investment into $1,000,000.

The science has been proven, the element of time is the variable.

I wish to thank all the shorts on this board, for their incredible continual daily postings for this incredible buying opportunity,

This is not investment advise, consult your financial adviser.


Cheers.






Bullboard Posts